特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
947596

勃起不全 (ED) 治療薬の世界市場 - 予測・分析:2020年~2030年

Erectile Dysfunction Nutraceuticals Market Report 2020-2030: Forecasts by Type (Pharmaceuticals and Nutraceuticals), Distribution Channel, plus Profiles of Leading Companies and Regional/Leading National Market Analysis

出版日: | 発行: Visiongain Ltd | ページ情報: 英文 169 Pages | 納期: 即日から翌営業日

価格
価格表記: GBPを日本円(税抜)に換算
本日の銀行送金レート: 1GBP=139.25円

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

勃起不全 (ED) 治療薬の世界市場 - 予測・分析:2020年~2030年
出版日: 2020年04月17日
発行: Visiongain Ltd
ページ情報: 英文 169 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の勃起不全 (ED) 治療薬市場について調査分析し、市場概要、市場力学、市場予測、主要企業などについて、体系的な情報を提供しています。

目次

第1章 世界の勃起不全 (ED) 治療薬市場

第2章 エグゼクティブサマリー

第3章 世界の勃起不全 (ED) 治療薬市場の動向

  • イントロダクション
  • 市場動向分析
  • SWOT分析
  • 業界分析:ファイブフォース分析
  • 業界分析:PEST分析

第4章 世界の勃起不全 (ED) 治療薬市場規模予測:タイプ別

  • 医薬品
  • 栄養補助食品

第5章 世界の勃起不全 (ED) 治療薬市場規模予測:医薬品別

  • Viagra (sildenafil citrate)
  • Cialis (tadalafil)
  • Levitra/ staxyn (Vardenafil)
  • Stendra/Spedra (avanafil)
  • Zydena (udenafil)
  • Vitaros (alprostadil)

第6章 世界の勃起不全 (ED) 治療薬市場規模予測:栄養補助食品別

  • 栄養補助食品
  • ハーブ/自然
  • その他

第7章 世界の勃起不全 (ED) 治療薬市場規模予測:流通チャネル別

  • 病院薬局
  • 小売薬局
  • オンライン薬局

第8章 地域別・主要国の勃起不全 (ED) 治療薬市場予測

第9章 北米の勃起不全 (ED) 治療薬市場

第10章 欧州の勃起不全 (ED) 治療薬市場

第11章 アジア太平洋の勃起不全 (ED) 治療薬市場

第12章 その他の世界の地域の勃起不全 (ED) 治療薬市場

第13章 勃起不全 (ED) 治療薬市場の主要企業

  • Bayer AG
  • Eli Lilly and Company
  • Ferring B.V.
  • GSK
  • Pfizer Inc.
  • Teva Pharmaceuticals
  • Vivus Inc.
  • Dong Pharmaceuticals
  • SK Chemicals Co Ltd.
  • Apricus Biosciences Inc.

第14章 結論・提言

第15章 付録

図表

List of Tables

  • Table 1. Global Erectile Dysfunction Market CAGR Forecast by Region 2020, 2025, 2030 (CAGR %)
  • Table 2. Global Erectile Dysfunction Market Snapshot (2020-2030)
  • Table 3. Global Erectile Dysfunction Market Forecast by Type, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 4. Pharmaceuticals Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 5. Nutraceuticals Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 6. Global Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 7. Viagra (sildenafil citrate) Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 8. Cialis (tadalafil) Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 9. Levitra/ staxyn (Vardenafil) Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 10. Stendra/Spedra (avanafil) Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 11. Zydena (udenafil) Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 12. Vitaros (alprostadil) Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 13. Global Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 14. Dietary Supplements Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 15. Global Dietary Supplements Market Forecast by Type, 2020-2030 (US$ million, CAGR %)
  • Table 16. Herbal/Natural Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 17. Global Herbal/Natural Market Forecast by Type, 2020-2030 (US$ million, CAGR %)
  • Table 18. Others Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 19. Global Erectile Dysfunction Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 20. Hospital Pharmacies Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 21. Retail Pharmacies Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 22. Online Pharmacies Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 23. Global Erectile Dysfunction Market CAGR Forecast by Region 2020, 2025, 2030 (%)
  • Table 24. North America Erectile Dysfunction Market Forecast by Type, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 25. North America Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 26. North America Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 27. North America Erectile Dysfunction Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 28. U.S. Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 29. Canada Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 30. Europe Erectile Dysfunction Market Forecast by Type, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 31. Europe Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 32. Europe Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 33. Europe Erectile Dysfunction Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 34. Germany Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 35. France Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 36. UK Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 37. Italy Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 38. Spain Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 39. Rest of Europe Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 40. Asia Pacific Erectile Dysfunction Market Forecast by Type, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 41. Asia Pacific Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 42. Asia Pacific Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 43. Asia Pacific Erectile Dysfunction Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 44. Japan Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 45. China Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 46. India Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 47. Australia Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 48. ASEAN Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 49. Rest of Asia Pacific Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 50. Rest of the World (RoW) Erectile Dysfunction Market Forecast by Type, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 51. Rest of the World (RoW) Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 52. Rest of the World (RoW) Erectile Dysfunction Market Forecast by Nutraceuticals, 2020- 2030 (US$ million, AGR %, CAGR %)
  • Table 53. Rest of the World (RoW) Erectile Dysfunction Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 54. Brazil Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 55. Mexico Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 56. GCC Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 57. South Africa Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 58. Rest of RoW Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 59. Bayer AG Profile 2020 (Business Segment in the Market, HQ, Company Type, Founded)
  • Table 60. Bayer AG Total Company Sales 2017-2019 (US million, AGR %)
  • Table 61. Bayer AG Mergers and Acquisitions (Date, Company Involved, Value US$ million, Details)
  • Table 62. Eli Lilly and Company Profile 2020 (Business Segment in the Market, HQ, Company Type, Founded)
  • Table 63. Eli Lilly and Company Total Company Sales 2017-2019 (US$ million, AGR %)
  • Table 64. Eli Lilly and Company Mergers and Acquisitions (Date, Company Involved, Value US$ million, Details)
  • Table 65. Ferring B.V. Profile 2020 (Business Segment in the Market, HQ, Company Type, Founded)
  • Table 66. Ferring B.V. Total Company Sales 2017-2019 (US$ million, AGR %)
  • Table 67. Ferring B.V. Mergers and Acquisitions (Date, Company Involved, Value US$ million, Details)
  • Table 68. GSK Profile 2020 (Business Segment in the Market, HQ, Company Type, Founded)
  • Table 69. GSK Total Company Sales 2017-2019 (US$ million, AGR %)
  • Table 70. GSK Mergers and Acquisitions (Date, Company Involved, Value US$ million, Details)
  • Table 71. Pfizer Inc. Profile 2020 (Business Segment in the Market, HQ, Company Type, Founded)
  • Table 72. Pfizer Inc. Total Company Sales 2017-2019 (US$ billion, AGR %)
  • Table 73. Pfizer Inc. Mergers and Acquisitions (Date, Company Involved, Value US$ million, Details)
  • Table 74. Teva Pharmaceuticals Profile 2020 (Business Segment in the Market, HQ, Company Type, Founded)
  • Table 1. Teva Pharmaceuticals Total Company Sales 2017-2019 (US$ billion, AGR %)
  • Table 2. Teva Pharmaceuticals Mergers and Acquisitions (Date, Company Involved, Value US$ million, Details)
  • Table 3. Vivus Inc. Profile 2020 (Business Segment in the Market, HQ, Company Type, Founded)
  • Table 4. Vivus Inc. Total Company Sales 2017-2019 (US$ million, AGR %)
  • Table 5. Vivus Inc. Mergers and Acquisitions (Date, Company Involved, Value US$ million, Details)
  • Table 6. Dong Pharmaceuticals Profile 2020 (Business Segment in the Market, HQ, Company Type, Founded)
  • Table 7. Dong Pharmaceuticals Total Company Sales 2017-2019 (US$ million, AGR %)
  • Table 8. Dong Pharmaceuticals Mergers and Acquisitions (Date, Company Involved, Value US$ million, Details)
  • Table 9. SK Chemicals Co Ltd. Profile 2020 (Business Segment in the Market, HQ, Company Type, Founded)
  • Table 10. SK Chemicals Co Ltd. Total Company Sales 2017-2019 (US$ million, AGR %)
  • Table 11. SK Chemicals Co Ltd. Mergers and Acquisitions (Date, Company Involved, Value US$ million, Details)
  • Table 12. Apricus Biosciences Inc. Profile 2020 (Business Segment in the Market, HQ, Company Type, Founded)
  • Table 13. Apricus Biosciences Inc. Total Company Sales 2017-2019 (US$ million, AGR %)
  • Table 14. Apricus Biosciences Inc. Mergers and Acquisitions (Date, Company Involved, Value US$ million, Details)

List of Figures

  • Figure 1. Research Methodology Snapshot, Erectile Dysfunction Market, 2020
  • Figure 2. Global Erectile Dysfunction Market Segmentation
  • Figure 3. Global Erectile Dysfunction Market Drivers & Restraints, 2020-2030
  • Figure 4. SWOT Analysis -- Erectile Dysfunction Market, 2020
  • Figure 5. Porter's Analysis -- Erectile Dysfunction Market, 2020
  • Figure 6. PEST Analysis -- Erectile Dysfunction Market, 2020
  • Figure 7. Global Erectile Dysfunction Market Forecast by Type, 2020-2030 (US$ million, AGR %)
  • Figure 8. Global Erectile Dysfunction Market Share Forecast by Type, 2020, 2025, 2030 (%)
  • Figure 9. Pharmaceuticals Revenue Forecast 2020-2030 (US$ million, AGR %)
  • Figure 10. Nutraceuticals Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 11. Global Erectile Dysfunction Market by Pharmaceuticals,2020-2030
  • Figure 12. Global Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030 (US$ million, AGR %)
  • Figure 13. Global Erectile Dysfunction Market Share Forecast by Pharmaceuticals, 2020, 2025, 2030 (%)
  • Figure 14. Viagra (sildenafil citrate) Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 15. Cialis (tadalafil) Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 16. Levitra/ staxyn (Vardenafil) Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 17. Stendra/Spedra (avanafil) Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 18. Zydena (udenafil) Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 19. Vitaros (alprostadil) Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 20. Global Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030 (US$ million, AGR %)
  • Figure 21. Global Erectile Dysfunction Market Share Forecast by Nutraceuticals, 2020, 2025, 2030 (%)
  • Figure 22. Dietary Supplements Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 23. Global Dietary Supplements Market Forecast by Type, 2020-2030 (US$ million, AGR %)
  • Figure 24. Herbal/Natural Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 25. Global Herbal/Natural Market Forecast by Type, 2020-2030 (US$ million, AGR %)
  • Figure 26. Others Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 27. Global Erectile Dysfunction Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR %)
  • Figure 28. Global Erectile Dysfunction Market Share Forecast by Distribution Channel, 2020, 2025, 2030 (%)
  • Figure 29. Hospital Pharmacies Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 30. Retail Pharmacies Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 31. Online Pharmacies Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 32. Global Erectile Dysfunction Market Forecast by Region 2020-2030 (US$ million, AGR %)
  • Figure 33. Global Erectile Dysfunction Market Share Forecast by Region 2020, 2025, 2030 (%)
  • Figure 34. North America Erectile Dysfunction Market Forecast by Country 2020-2030 (US$ million, AGR %)
  • Figure 35. North America Erectile Dysfunction Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 36. North America Erectile Dysfunction Market Forecast by Type, 2020-2030 Revenue (US$ million), (AGR %)
  • Figure 37. North America Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030 Revenue (US$ million), (AGR %)
  • Figure 38. North America Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030 Revenue (US$ million), (AGR %)
  • Figure 39. North America Erectile Dysfunction Market Forecast by Distribution Channel, 2020- 2030 Revenue (US$ million), (AGR %)
  • Figure 40. U.S. Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 41. Canada Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 42. Europe Erectile Dysfunction Market Forecast by Country 2020-2030 (US$ million, AGR %)
  • Figure 43. Europe Erectile Dysfunction Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 44. Europe Erectile Dysfunction Market Forecast by Type, 2020-2030 Revenue (US$ million), (AGR %)
  • Figure 45. Europe Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030 Revenue (US$ million), (AGR %)
  • Figure 46. Europe Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030 Revenue (US$ million), (AGR %)
  • Figure 47. Europe Erectile Dysfunction Market Forecast by Distribution Channel, 2020-2030 Revenue (US$ million), AGR (%)
  • Figure 48. Germany Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 49. France Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 50. UK Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 51. Italy Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 52. Spain Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 53. Rest of Europe Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 54. Asia Pacific Erectile Dysfunction Market Forecast by Country 2020-2030 (US$ million, AGR %)
  • Figure 55. Asia Pacific Erectile Dysfunction Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 56. Asia Pacific Erectile Dysfunction Market Forecast by Type, 2020-2030 Revenue (US$ million), (AGR %)
  • Figure 57. Asia Pacific Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030 Revenue (US$ million) (AGR %)
  • Figure 58. Asia Pacific Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030 Revenue (US$ million), (AGR %)
  • Figure 59. Asia Pacific Erectile Dysfunction Market Forecast by Distribution Channel, 2020-2030 (AGR %)
  • Figure 60. Japan Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 61. China Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 62. India Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 63. Australia Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 64. ASEAN Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 65. Rest of Asia Pacific Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 66. Rest of the World (RoW) Erectile Dysfunction Market Forecast by Country 2020-2030 (US$ million, AGR %)
  • Figure 67. Rest of the World (RoW) Erectile Dysfunction Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 68. Rest of the World (RoW) Erectile Dysfunction Market Forecast by Type, 2020-2030 Revenue (US$ million), (AGR %)
  • Figure 69. Rest of the World (RoW) Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030 (AGR %)
  • Figure 70. Rest of the World (RoW) Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030 (AGR %)
  • Figure 71. Rest of the World (RoW) Erectile Dysfunction Market Forecast by Distribution Channel, 2020-2030 (AGR %)
  • Figure 72. Brazil Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 73. Mexico Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 74. GCC Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 75. South Africa Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 76. Rest of RoW Erectile Dysfunction Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 77. Bayer AG Total Company Sales 2017-2019 (US$ million, AGR %)
  • Figure 78. Eli Lilly and Company Total Company Sales 2017-2019 (US$ million, AGR %)
  • Figure 79. GSK Total Company Sales 2017-2019 (US$ million, AGR %)
  • Figure 80. Pfizer Inc. Total Company Sales 2017-2019 (US$ bn, AGR %)
  • Figure 81. Teva Pharmaceuticals Total Company Sales 2017-2019 (US$ billion, AGR %)
  • Figure 82. Vivus Inc. Total Company Sales 2017-2019 (US$ million, AGR %)
  • Figure 83. SK Chemicals Co Ltd. Total Company Sales 2017-2019 (US$ million, AGR %)
  • Figure 84. Global Erectile Dysfunction Market Forecast by Region 2020-2030 (US$ million, AGR %)
  • Figure 85. Global Erectile Dysfunction Market Share Forecast by Region 2020, 2025, 2030 (%)
目次
Product Code: PHA0716

Title:
Erectile Dysfunction Nutraceuticals Market Report 2020-2030
Forecasts by Type (Pharmaceuticals (Viagra (Sildenafil Citrate), Cialis (Tadalafil), Levitra/Staxyn (Vardenafil), Stendra/Spedra (Avanafil), Zydena (Udenafil), Vitaros (Alprostadil)) and Nutraceuticals (Dietary Supplements (DHEA, VIgRX Plus, IDIProst, Prelox, Tradamix TX 1000, Others); HerbalNatural, (Horny Goat Weed, Ginko, Red Ginseng, Yohimbine, Panax Ginseng, Cappra, Pyongenol, Lepidamax, REVACTIN, Others)), Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies). PLUS Profiles of Leading Companies) and Regional and Leading National Market Analysis.

Erectile Dysfunction-our new study reveals trends, R&D progress, and predicted revenues

Where is the erectile dysfunction market heading? If you are involved in this sector you must read this newly updated report. Visiongain's report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead

Our 168 pages report provides 88 tables, 85 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Erectile Dysfunction Market. See how to exploit the opportunities.

Forecasts to 2030 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets

Along with revenue prediction for the overall world market, there are following segments, each forecasted at a global and regional level.

Erectile Dysfunction Market by Type

Pharmaceuticals

  • Viagra (Sildenafil Citrate)
  • Cialis (Tadalafil)
  • Levitra/ Staxyn (Vardenafil)
  • Stendra/Spedra (Avanafil)
  • Zydena (Udenafil)
  • Vitaros (alprostadil)

Nutraceuticals

Dietary Supplements:

  • DHEA
  • VIgRX Plus
  • IDIProst
  • Prelox
  • Tradamix TX 1000
  • Others

Herbal/Natural:

  • Horny Goat Weed
  • Ginko
  • Red Ginseng
  • Yohimbine
  • Panax Ginseng
  • Cappra
  • Pyongenol
  • Lepidamax
  • REVACTIN
  • Others

Others

Erectile Dysfunction Market by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 4 regional and 15 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe

Asia pacific

  • Japan
  • China
  • India
  • Australia
  • ASEAN
  • Rest of Asia Pacific

Rest of the World

  • Brazil
  • Mexico
  • GCC
  • South Africa
  • Rest of ROW

The report also includes profiles and for some of the leading companies in the erectile dysfunction market.

Leading companies and the potential for market growth

Overall world revenue for Erectile Dysfunction Market will surpass $2,500 million in 2020, our work calculates. We predict noticeable revenue growth through to 2030.

Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Erectile Dysfunction Market report helps you

In summary, our 169 pages report provides you with the following knowledge:

Revenue forecasts to 2030 for 5 regional and 17 key national markets

See forecasts for the Erectile Dysfunction market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, Australia, ASEAN countries, GCC Countries and South Africa.

Prospects for established firms and those seeking to enter the market

Including company profiles for 10 of the major companies involved in the erectile dysfunction market:

  • Bayer AG
  • Eli Lilly and Company
  • Ferring B.V.
  • GSK
  • Pfizer Inc.
  • Teva Pharmaceuticals
  • Vivus Inc.
  • Dong Pharmaceuticals
  • SK Chemicals Co Ltd.
  • Apricus Biosciences Inc.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain's study is for everybody needing commercial analyses for the Erectile Dysfunction market and leading companies. You will find data, trends and predictions.

Buy our report today Erectile Dysfunction Market Report 2020-2030: Forecasts by Type (Pharmaceuticals (Viagra (Sildenafil Citrate), Cialis (Tadalafil), Levitra/Staxyn (Vardenafil), Stendra/Spedra (Avanafil), Zydena (Udenafil), Vitaros (Alprostadil)) and Nutraceuticals (Dietary Supplements (DHEA, VIgRX Plus, IDIProst, Prelox, Tradamix TX 1000, Others); HerbalNatural, (Horny Goat Weed, Ginko, Red Ginseng, Yohimbine, Panax Ginseng, Cappra, Pyongenol, Lepidamax, REVACTIN, Others)), Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies). PLUS Profiles of Leading Companies) and Regional and Leading National Market Analysis. Avoid missing out by staying informed - order our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Global Erectile Dysfunction Market 2020-2030

  • 1.1 Market Overview
  • 1.1 Why You Should Read This Report
  • 1.2 What This Report Delivers
  • 1.3 Key Questions Answered By This Analytical Report Include:
  • 1.4 Who is This Report For?
  • 1.5 Methodology
  • 1.6 Frequently Asked Questions (FAQs)
  • 1.7 Associated Visiongain Reports
  • 1.8 About Visiongain

2 Executive Summary

  • 2.1 Erectile Dysfunction Definition
  • 2.2 Research Scope & Methodology
  • 2.3 Erectile Dysfunction Market
    • 2.3.1 Global Erectile Dysfunction Market Segmentation

3 Global Erectile Dysfunction Market Trends

  • 3.1 Introduction
  • 3.2 Market Trend Analysis
    • 3.2.1 Drivers
    • 3.2.2 Challenges Faced by Erectile Dysfunction Market
    • 3.2.3 Restraints of Erectile Dysfunction Market
    • 3.2.4 Key Opportunities
  • 3.3 SWOT Analysis
    • 3.3.1 Strength
    • 3.3.2 Weakness
    • 3.3.3 Opportunity
    • 3.3.4 Threat
  • 3.4 Industry analysis-Porter's
    • 3.4.1 Threat of New Entrants (Low)
    • 3.4.2 Bargaining Power of Suppliers (Low)
    • 3.4.3 Bargaining Power of Buyers (Moderate)
    • 3.4.4 Threat of Substitutes (Moderate)
    • 3.4.5 Competitive Rivalry (High)
  • 3.5 Industry analysis-PEST
    • 3.5.1 Political (Neutral)
    • 3.5.2 Economical (Favourable)
    • 3.5.3 Social (Neutral)
    • 3.5.4 Technological (Strong)

4 Global Erectile Dysfunction Market Size Forecast 2020-2030 by Type

  • 4.1.1 Pharmaceuticals Forecast 2020-2030
  • 4.1.2 Nutraceuticals Forecast 2020-2030

5 Global Erectile Dysfunction Market Size Forecast 2020-2030 by Pharmaceuticals

  • 5.1.1 Viagra (sildenafil citrate) Forecast 2020-2030
  • 5.1.2 Cialis (tadalafil) Forecast 2020-2030
  • 5.1.3 Levitra/ staxyn (Vardenafil) Forecast 2020-2030
  • 5.1.4 Stendra/Spedra (avanafil) Forecast 2020-2030
  • 5.1.5 Zydena (udenafil) Forecast 2020-2030
  • 5.1.6 Vitaros (alprostadil) Forecast 2020-2030

6 Global Erectile Dysfunction Market Size Forecast 2020-2030 by Nutraceuticals

  • 6.1.1 Dietary Supplements Forecast 2020-2030
  • 6.1.2 Herbal/ Natural Forecast 2020-2030
  • 6.1.3 Others Forecast 2020-2030

7 Global Erectile Dysfunction Market Size by Distribution Channel, Forecast 2020-2030

  • 7.1.1 Hospital Pharmacies Forecast 2020-2030
  • 7.1.2 Retail Pharmacies Forecast 2020-2030
  • 7.1.3 Online Pharmacies Forecast 2020-2030

8 Regional and Leading National Erectile Dysfunction Market Forecasts 2020-2030

  • 8.1 Global Erectile Dysfunction Market by National Market Share Forecast 2020-2030

9 North America Erectile Dysfunction Market

  • 9.1 North America Erectile Dysfunction Market by Country Market Share Forecast 2020-2030
  • 9.2 North America Erectile Dysfunction Market Forecast by Type, 2020-2030
  • 9.3 North America Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030
  • 9.4 North America Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030
  • 9.5 North America Erectile Dysfunction Market Forecast by Distribution Channel, 2020-
  • 9.6 U.S. Erectile Dysfunction Market Forecast 2020-2030
  • 9.7 Canada Erectile Dysfunction Market Forecast 2020-2030

10 Europe Erectile Dysfunction Market by Country Market Share Forecast 2020-2030

  • 10.1 Europe Erectile Dysfunction Market Forecast by Type, 2020-2030
  • 10.2 Europe Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030
  • 10.3 Europe Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030
  • 10.4 Europe Erectile Dysfunction Market Forecast by Distribution Channel, 2020-2030
  • 10.5 Germany Erectile Dysfunction Market Forecast 2020-2030
  • 10.6 France Erectile Dysfunction Market Forecast 2020-2030
  • 10.7 UK Erectile Dysfunction Market Forecast 2020-2030
  • 10.8 Italy Erectile Dysfunction Market Forecast 2020-2030
  • 10.9 Spain Erectile Dysfunction Market Forecast 2020-2030
  • 10.10 Rest of Europe Erectile Dysfunction Market Forecast 2020-2030

11 Asia Pacific Erectile Dysfunction Market by Country, Forecast 2020-2030

  • 11.1 Asia Pacific Erectile Dysfunction Market Forecast by Type, 2020-2030
  • 11.2 Asia Pacific Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030
  • 11.3 Asia Pacific Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030
  • 11.4 Asia Pacific Erectile Dysfunction Market Forecast by Distribution Channel, 2020-
  • 11.5 Japan Erectile Dysfunction Market Forecast 2020-2030
  • 11.6 China Erectile Dysfunction Market Forecast 2020-2030
  • 11.7 India Erectile Dysfunction Market Forecast 2020-2030
  • 11.8 Australia Erectile Dysfunction Market Forecast 2020-2030
  • 11.9 ASEAN Erectile Dysfunction Market Forecast 2020-2030
  • 11.10 Rest of Asia Pacific Erectile Dysfunction Market Forecast 2020-2030

12 Rest of the World (RoW) Erectile Dysfunction Market by Country Market Share Forecast 2020-2030

  • 12.1 Rest of the World (RoW) Erectile Dysfunction Market Forecast by Type, 2020-2030
  • 12.2 Rest of the World (RoW) Erectile Dysfunction Market Forecast by Pharmaceuticals, 2020-2030
  • 12.3 Rest of the World (RoW) Erectile Dysfunction Market Forecast by Nutraceuticals, 2020-2030
  • 12.4 Rest of the World (RoW) Erectile Dysfunction Market Forecast by Distribution Channel, 2020-2030
  • 12.5 Brazil Erectile Dysfunction Market Forecast 2020-2030
  • 12.6 Mexico Erectile Dysfunction Market Forecast 2020-2030
  • 12.7 GCC Erectile Dysfunction Market Forecast 2020-2030
  • 12.8 South Africa Erectile Dysfunction Market Forecast 2020-2030
  • 12.9 Rest of RoW Erectile Dysfunction Market Forecast 2020-2030

13 Leading Companies in the Erectile Dysfunction Market

  • 13.1 Bayer AG
    • 13.1.1 Bayer AG Total Company Sales 2017-2019
    • 13.1.2 Bayer AG Erectile Dysfunction Products / Services
    • 13.1.3 Bayer AG. Mergers & Acquisitions (M&A) Activity
  • 13.2 Eli Lilly and Company
    • 13.2.1 Eli Lilly and Company Total Company Sales 2017-2019
    • 13.2.2 Eli Lilly and Company Erectile Dysfunction Products / Services
    • 13.2.3 Eli Lilly and Company. Mergers & Acquisitions (M&A) Activity
  • 13.3 Ferring B.V.
    • 13.3.1 Ferring B.V. Erectile Dysfunction Products / Services
    • 13.3.2 Ferring B.V. Mergers & Acquisitions (M&A) Activity
  • 13.4 GSK
    • 13.4.1 GSK Total Company Sales 2017-2019
    • 13.4.2 GSK Erectile Dysfunction Products / Services
    • 13.4.3 GSK. Mergers & Acquisitions (M&A) Activity
  • 13.5 Pfizer Inc.
    • 13.5.1 Pfizer Inc. Total Company Sales 2017-2019
    • 13.5.2 Pfizer Inc. Erectile Dysfunction Products / Services
    • 13.5.3 Pfizer Inc. Mergers & Acquisitions (M&A) Activity
  • 13.6 Teva Pharmaceuticals
    • 13.6.1 Teva Pharmaceuticals Total Company Sales 2017-2019
    • 13.6.1 Teva Pharmaceuticals Erectile Dysfunction Products / Services
    • 13.6.2 Teva Pharmaceuticals. Mergers & Acquisitions (M&A) Activity
  • 13.7 Vivus Inc.
    • 13.7.1 Vivus Inc. Total Company Sales 2017-2019
    • 13.7.2 Vivus Inc. Erectile Dysfunction Products / Services
    • 13.7.3 Vivus Inc. Mergers & Acquisitions (M&A) Activity
  • 13.8 Dong Pharmaceuticals
    • 13.8.1 Dong Pharmaceuticals Erectile Dysfunction Products / Services
    • 13.8.2 Dong Pharmaceuticals. Mergers & Acquisitions (M&A) Activity
  • 13.9 SK Chemicals Co Ltd.
    • 13.9.1 SK Chemicals Co Ltd. Total Company Sales 2017-2019
    • 13.9.2 SK Chemicals Co Ltd. Erectile Dysfunction Products / Services
    • 13.9.3 SK Chemicals Co Ltd. Mergers & Acquisitions (M&A) Activity
  • 13.10 Apricus Biosciences Inc.
    • 13.10.1 Apricus Biosciences Inc. Erectile Dysfunction Products / Services
    • 13.10.2 Apricus Biosciences Inc. Mergers & Acquisitions (M&A) Activity

14 Conclusions and Recommendations

  • 14.1 Associated Visiongain Reports
    • Visiongain Report Sales Order Form

15 Appendix A

  • 15.1 About Visiongain
    • Appendix B
  • 15.2 Visiongain report evaluation form
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.